Insider trades
David Krempa, Chief Officer of Eton Pharmaceuticals ETON, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $3.2M. The latest trade was on 06/26.
David Krempa
Chief Business Officer
- Company
- Eton Pharmaceuticals ETON
- First filing
- 24/02/15
- Trades
- 28 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$3.2M
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ETON | Open-market sale | 05/22–05/27 | 05/27 | 100,000 sh5 trades | $32.30avg. | $3,229,716.95 | −79.8% |
ETON | Open-market sale | 25/06/12–25/06/16 | 25/06/16 | 34,000 sh3 trades | $14.83avg. | $504,317.63 | −5.3% |